Clinics evaluating a new energy-based device are usually weighing up several options at once, and the comparison has a habit of collapsing into a spec-sheet exercise — wavelength, pulse duration, spot size — without ever reaching the question that actually matters. How does this device change what you can offer patients, and how does it change the way the appointment book fills up? A useful vascular laser comparison starts there and works backwards to the technical detail, rather than the other way round.
A Single-Wavelength Vascular Laser and a Dual-Wavelength Platform Are Not the Same Purchase
Most established vascular and pigmentation devices rely on a single wavelength, tuned to be absorbed by either haemoglobin or melanin, but rarely both effectively. That forces a choice at the point of purchase: a device optimised for thread veins and redness, or one optimised for pigmentation, with a compromise somewhere in the middle.
ADVATx pairs a 589nm yellow wavelength, absorbed strongly by oxyhaemoglobin, with a 1319nm infrared wavelength that is water-absorbed rather than melanin-targeted. That combination is what allows a single platform to cover vascular and rejuvenation work without swapping devices. The practical consequence is that the comparison is not really wavelength against wavelength. It is one platform against two — and the second device brings its own capital cost, service contract, training requirement and treatment room.
Bruising, Purpura and What “No Downtime” Actually Means
Downtime is the most loosely used word in device marketing, and it is worth pinning down what each manufacturer means by it. Some devices produce no visible change beyond a brief flush. Others produce several days of manageable but noticeable redness or purpura that patients will certainly notice and may need to plan around.
Pulsed dye lasers are the obvious comparison point for vascular work, and they remain effective devices. Their mechanism relies on more aggressive coagulation of the target vessel, which is why purpura has historically been part of the treatment conversation. ADVATx delivers its 589nm energy differently and requires no topical anaesthetic or numbing, which is the basis of its lower-purpura positioning. When you compare, ask each manufacturer to define downtime in days and visible signs rather than adjectives, and ask what proportion of patients experience each.
Skin Type Coverage — Ask What Settings That Clearance Assumes
Skin type coverage is worth verifying directly rather than accepting at face value. Ask specifically which Fitzpatrick types a competing device is cleared for and, more revealingly, at what settings. Some single-wavelength devices are technically usable on deeper skin tones only at substantially reduced energy, which means reduced efficacy, more sessions, or both.
ADVATx is approved for skin types I–V, and the reason is mechanical rather than a matter of protocol caution. Because the 1319nm wavelength is water-absorbed rather than melanin-targeted, competing absorption by epidermal melanin is less of a limiting factor. For a clinic serving a genuinely mixed patient base, this is one of the more consequential lines in the entire comparison, and it is covered in more depth in our guide to laser safety across skin types.
Indication Breadth Changes the Maths
Compare indication breadth honestly, and compare it against your own treatment menu rather than in the abstract. A device cleared narrowly for vascular work needs pairing with something else for pigmentation, acne or rejuvenation, which doubles both the capital outlay and the training burden to cover the same span of patient concerns.
ADVATx carries 25 FDA- and CE-cleared indications. These span vascular conditions such as telangiectasia, port-wine stains and cherry angiomas, along with pigmentary concerns including melasma and hyperpigmentation. They also cover inflammatory acne and atrophic acne scarring, rosacea, psoriasis, striae, and skin rejuvenation including fine lines and pore reduction. The useful question is not how many indications look impressive on a brochure, but how many you would realistically build a treatment around in the next twelve months.
Consumables Are Where Comparisons Quietly Diverge
Two devices with similar purchase prices can have very different economics once they are running. Some vascular platforms rely on dye kits, single-use tips or treatment cards that consume a portion of every treatment fee. ADVATx uses no dye kits and no treatment cards, so there is no per-treatment consumable cost to model.
Put this into a spreadsheet rather than leaving it as a general impression. Take your expected monthly session volume, multiply by each device’s per-treatment consumable cost, and look at the annual figure. On realistic volumes, the gap between a consumable-free platform and a cartridge-based one is frequently larger than the difference in sticker price the comparison started with. Our breakdown of consumables, maintenance and total cost of ownership works through the full calculation.
What to Actually Ask Each Manufacturer
A short, consistent list of questions put to every manufacturer will tell you more than any brochure. Ask which Fitzpatrick skin types the device is cleared for and at what settings. Ask how many cleared indications it holds, and which ones manufacturers have seen clinics build a real menu around. Ask for the per-treatment consumable cost and the annual service contract cost as separate figures.
Then ask the questions manufacturers are less used to answering. What proportion of patients experience purpura or visible redness, and for how long? Is a topical anaesthetic required? What does training and onboarding involve, who delivers it, and what does it cost after the first year? Can you see before-and-after data from UK clinics treating a patient base like yours? Ask the same questions of everyone, put the answers in a single table, and the decision usually resolves itself.
Judge Outcomes on Comparable Evidence
Our results gallery is a reasonable benchmark for the kinds of outcomes to expect, and any clinic mid-evaluation should ask competing manufacturers for equivalent before-and-after data rather than relying on marketing claims. Look for consistent lighting, stated session counts and stated intervals between images. Photographs without those details are difficult to compare with anything.
Insist on a trial session or an in-clinic demonstration before committing. How a device performs on paper and how it performs on your own patient base, in your hands, in your room, can differ — and a demonstration is the cheapest way to find out which.
Book a Demo to Compare for Yourself
If you are running a vascular laser comparison across several devices, the most useful next step is seeing ADVATx alongside the alternatives you are considering. Book a demo to discuss how it would fit your treatment menu, your patient base and the equipment you already own.
